Mount Sinai claims CVS stole $121M in federal prescription cash for poor New Yorkers: fraud suit
Mount Sinai has filed a lawsuit against CVS, alleging that the pharmacy chain stole $121 million from federal funds intended for low-income patients. The lawsuit claims CVS implemented a secret pricing scheme to divert money from the federal 340B drug discount program. Mount Sinai argues that this fraudulent activity has harmed its ability to provide care to uninsured and under-insured individuals in New York City.
- ▪Mount Sinai accuses CVS of orchestrating a $121 million racketeering scheme.
- ▪The lawsuit claims CVS used a secret pricing scheme to manipulate reimbursement rates.
- ▪CVS allegedly refused to provide audit data as required by their contract with Mount Sinai.
Opening excerpt (first ~120 words) tap to expand
Metro Mount Sinai claims CVS stole $121M in federal prescription cash for poor New Yorkers: fraud suit By Peter Senzamici Published May 21, 2026, 4:48 p.m. ET See more of our coverage in your search results. Add The New York Post on Google Mount Sinai is suing pharmacy giant CVS, accusing it of a $121 million racketeering scheme that siphoned federal prescription drug cash meant for the city’s poorest patients. The sprawling hospital system claims CVS orchestrated a “secret pricing scheme” to pocket massive savings afforded by the federal 340B drug discount program, according to a lawsuit in Manhattan federal court. The alleged fraud scheme deprived Mount Sinai of crucial funds meant for vulnerable, uninsured New Yorkers, claims the suit, filed Monday.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at New York Post.
Discussion
0 commentsMore from New York Post
